Virtu Financial LLC - TRACON PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 33 filers reported holding TRACON PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Virtu Financial LLC ownership history of TRACON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$8
-88.1%
28,362
-37.4%
0.00%
-88.9%
Q4 2022$67
-99.9%
45,279
+203.1%
0.01%
+80.0%
Q3 2021$58,000
-81.6%
14,938
-75.6%
0.01%
-90.7%
Q3 2020$316,000
+315.8%
61,180
+58.3%
0.05%
+500.0%
Q2 2020$76,000–38,650–0.01%–
 Download
Other shareholders
TRACON PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Opaleye Management Inc. 4,764,508$848,0820.28%
Ikarian Capital, LLC 2,765,530$492,2650.06%
JOHNSON & JOHNSON 84,003$14,9530.01%
BOOTHBAY FUND MANAGEMENT, LLC 258,844$46,0740.00%
BlackRock Inc. 267,821$47,6730.00%
Bank of New York Mellon Corp 10,259$1,8260.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 15,835$2,8190.00%
Truvestments Capital LLC 318$570.00%
Tower Research Capital LLC (TRC) 10,407$1,8520.00%
Cutler Group LLC / CA 1,200$00.00%
View complete list of TRACON PHARMACEUTICALS INC shareholders